Little Correlation Seen Between Patient, Clinician Vitiligo Disease Activity, Severity Index
Additional studies designed to develop a clinical score that is reflective of signs of disease activity are warranted.
Additional studies designed to develop a clinical score that is reflective of signs of disease activity are warranted.
Although many surgical techniques for the treatment of vitiligo exist, response is variable.
In patients with vitiligo, treatment with the Janus kinase inhibitor tofacitinib resulted in repigmentation when there was concomitant light exposure.
The cost burden associated with vitiligo is high, although no evidence exists for the value of vitiligo treatments.